This was the stock's second consecutive day of gains.
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
23hon MSN
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results